The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Landiolol is a selective beta-1 adrenergic ...

Shares of Milestone Pharmaceuticals Inc. gained 25.4% in premarket trading on Monday after the company said its experimental treatment for paroxysmal supraventricular tachycardia met the primary ...

Please provide your email address to receive an email when new articles are posted on . A fast-acting nasal spray was safe and effective for patients self-treating for repeated episodes of paroxysmal ...

This type of tachycardia is uncommon today because of the reduced use of theophylline in the treatment of pulmonary disease. Multifocal atrial tachycardia is gradual in onset because the underlying ...

The Agency has specifically requested clarification about the time of data recorded for adverse events in the phase 3 trials. The Food and Drug Administration (FDA) has issued a Refusal to File (RTF) ...

First and only contact force pulsed field ablation (PFA) system engineered to revolutionize care for the hundreds of thousands at risk of death from ventricular tachycardia (VT). FDA's TAP Pilot and ...

For most adults, the heart beats 60 to 100 times per minute. When someone’s heart beats more than 100 times per minute, they have a condition called tachycardia. During certain specific experiences, ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today it has received $3 million in grant funding (1R44HL169112) ...

Clinical trial evaluating a novel, non-invasive radiation treatment for ventricular tachycardia refractory to medication and catheter ablation The UAB Departments of Radiation Oncology and Cardiology ...